Top of page
Lawyers

Richard D. Truesdell, Jr.

Lawyers

Filters

Cempra, Inc. Common Stock Offering
Davis Polk advised the underwriters in connection with the SEC-registered offering of 4,166,167 shares of common stock of Cempra, Inc. The net proceeds to Cempra were approximately $93.7…
Markit Ltd. $200 Million Accelerated Share Repurchase
Davis Polk advised Markit Ltd. in connection with accelerated share repurchase transactions it entered into with each of the counterparties, pursuant to which Markit is repurchasing $200…
BankUnited, Inc. $400 Million Notes Offering
Davis Polk advised the representatives of the underwriters on an SEC-registered offering by BankUnited, Inc. of $400 million aggregate principal amount of 4.875% senior notes due 2025…
MSCI Inc. $800 Million Notes Offering
Davis Polk advised MSCI Inc. (“MSCI”) in connection with a Rule 144A/Regulation S offering of $800 million aggregate principal amount of its 5.750% senior notes due 2025. The notes are…
Celgene $8.0 Billion Notes Offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Celgene Corporation of $8.0 billion aggregate principal amount of notes. The notes were issued in…
Fogo de Chão, Inc. Initial Public Offering
Davis Polk advised Fogo de Chão, Inc. (“Fogo”) on its $101.5 million initial public offering of 5,073,528 shares of its common stock, par value $0.01 per share. The common stock is listed…
Biotie Therapies Corp. Initial Public Offering
Davis Polk advised Biotie Therapies Corp. (“Biotie”) on its $56.7 million U.S. initial public offering of 3,806,047 American Depositary Shares (“ADSs”) representing 304,483,760 ordinary…
Back to top